PCVX
Vaxcyte, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.1% ·
aandelenstroom -0.1% ·
netto nieuwe posities +8.3%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +1 | 85.77M | $4.99B | +6 | −4 |
| Q1 2026 | 115 | +4 | 93.55M | $5.43B | +8 | −5 |
| Q4 2025 | 111 | 0 | 92.90M | $4.29B | +2 | −1 |
| Q3 2025 | 18 | +2 | 60.74M | $2.19B | +3 | −2 |
| Q2 2025 | 14 | 0 | 57.50M | $1.87B | +1 | −1 |
| Q1 2025 | 11 | -1 | 19.96M | $753.77M | — | −1 |
| Q4 2024 | 12 | +1 | 18.46M | $1.51B | +1 | — |
| Q3 2024 | 10 | +2 | 13.93M | $1.59B | +3 | −1 |
| Q2 2024 | 8 | — | 11.72M | $885.19M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 4.54M | — | $371.60M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.44M | -1.6% | $363.79M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.97M | -11.2% | $324.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 3.97M | -11.2% | $324.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 2.80M | +3.8% | $229.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 2.80M | +3.8% | $229.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Norges Bank ✦ (passief) | 1.10M | -1.1% | $90.07M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 775.65K | +83.2% | $63.49M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 276.58K | -7.3% | $22.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 251.06K | -30.2% | $20.55M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 141.78K | +2316.6% | $11.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Duquesne Family Office ✦ | 86.27K | +100.8% | $7.06M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 54.08K | Nieuw | $4.43M | 0.0% | New | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 24.52K | +120.6% | $2.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 24.52K | +120.6% | $2.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 24.52K | +120.6% | $2.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $4.43M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 53.30K aandelen, $3,097 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.